Cargando…
Inhibition of SGK1 confers vulnerability to redox dysregulation in cervical cancer
Cervical cancer has poor prognosis and patients are often diagnosed at advanced stages of the disease with limited treatment options. There is thus an urgent need for the discovery of new therapeutic strategies in cervical cancer. The activation of SGK1 has been linked to the development of various...
Autores principales: | Wang, Min, Xue, Yijue, Shen, Lanlin, Qin, Pan, Sang, Xiaolin, Tao, Zhiwei, Yi, Jingyan, Wang, Jia, Liu, Pixu, Cheng, Hailing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536746/ https://www.ncbi.nlm.nih.gov/pubmed/31136958 http://dx.doi.org/10.1016/j.redox.2019.101225 |
Ejemplares similares
-
The SGK3-Catalase antioxidant signaling axis drives cervical cancer growth and therapy resistance
por: Wang, Min, et al.
Publicado: (2023) -
MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancer
por: Yi, Jingyan, et al.
Publicado: (2019) -
BTF3 confers oncogenic activity in prostate cancer through transcriptional upregulation of Replication Factor C
por: Zhang, Yuan, et al.
Publicado: (2021) -
Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylation
por: Xiao, Zhen, et al.
Publicado: (2019) -
Phenethyl Isothiocyanate Enhances the Cytotoxic Effects of PARP Inhibitors in High-Grade Serous Ovarian Cancer Cells
por: Jia, Yaxun, et al.
Publicado: (2022)